Anti-osteomyelitis drug and preparation technology thereof

A preparation process and osteomyelitis technology, which can be used in bone diseases, drug combinations, pharmaceutical formulations, etc., can solve the problems of unbearable pain patients, cumbersome treatment process, and other complications, and achieve scientific and reasonable drug configuration and good therapeutic effect. , good therapeutic effect

Inactive Publication Date: 2010-04-07
LAIYANG JIANGBO PHARMA
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

If the disease is not treated properly or cured in time in the early stage, it will turn into chronic suppurative osteomyelitis, which is more stubborn. Clinical surgery often uses surgical marrow replacement or amputation, and the severe pain is unbearable for patients.
[0003] At present, Western medicine or traditional Chinese medicine is generally used in the treatment of osteomyelitis. Although Western medicine has a quick effect, it has large toxic and side effects and high costs, and there may be other complications after the operation; Chinese medicine has little toxic and side effects on the human body and low cost, but The treatment process is cumbersome, and the patient needs to take a large amount of traditional Chinese medicine, some of which are hard to control when boiled, which reduces the efficacy of the traditional Chinese medicine, and the bitter taste of the traditional Chinese medicine makes it difficult for the patient to swallow

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-osteomyelitis drug and preparation technology thereof
  • Anti-osteomyelitis drug and preparation technology thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] A kind of preparation technology of anti-osteomyelitis drug of the present embodiment, refer to figure 1 Include the following steps:

[0036] 1. Ingredients, cooking

[0037] Put 50 parts of honeysuckle, 80 parts of dandelion, 80 parts of diding, 80 parts of Scutellaria barbata, 80 parts of Pulsatilla chinensis, and 80 parts of Hedyotis diffusa into a multi-functional extraction tank according to the ratio. Water, the ratio of water to medicinal materials is 5:1, heat and decoct for 50 minutes, extract the decoction and put it in a standing tank, add water to the above-mentioned medicinal residues, the ratio of water to medicinal residues is 3:1, heat again Decoct for 50 minutes, extract the decoction and place it in a static tank, and combine the two decoctions.

[0038] 2. Concentrate and collect ointment

[0039] Add the decoction liquid to the three-effect concentrated evaporator, heat to keep the liquid boiling at a certain degree, prevent the liquid medicine f...

Embodiment 2

[0050] The preparation process of a kind of anti-osteomyelitis drug of the present embodiment comprises the following steps:

[0051] 1. Ingredients, cooking

[0052] According to the ratio, put 70 parts of honeysuckle, 120 parts of dandelion, 120 parts of dandelion, 120 parts of Scutellaria barbata, 120 parts of pulsatilla, and 120 parts of Hedyotis diffusa into a multi-functional extraction tank, add water, water and medicinal materials The ratio is 7:1, heat and decoct for 70 minutes, extract the decoction and put it in a static tank, add water to the above-mentioned medicinal residues, the ratio of water to medicinal residues is 5:1, heat and decoct for 70 minutes, extract The decoction is placed in a standing tank, and the two decoctions are combined.

[0053] 2. Concentrate and collect ointment

[0054] Add the decoction to the three-effect concentrated evaporator, concentrate to a relative density of about 1.00-1.20, and transfer it to a vacuum concentration tank. Th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to an anti-osteomyelitis drug and a preparation technology thereof, belonging to the technical fields of drugs and preparation technology thereof. The drug is prepared by the following drug raw material components in parts by weight: 80-120 parts of Lonicera japonica, 80-120 parts of Taraxacum mongolicum, 80-120 parts of Bunge Corydalis Herb, 80-120 parts of Barbed Skullcap Herb, 80-120 parts of Chinese Pulsatilla Root and 80-120 parts of Spreading Hedyotis Herb. The preparation technology comprises the following steps: 1. batching and decocting; 2. concentrating and collecting paste; 3. crushing and sterilizing; 4. mixing and drying in vacuum; 5. crushing; 6. pelletizing and drying; 7. granular straightening and final blending; 8. tabletting; 9. coating; and 10. storing. The anti-osteomyelitis drug in the invention has the efficacies of clearing away heat and toxic material and eliminating stasis subdue swelling, has stable curative effect, high curative rate, convenient administration, low price and no toxic and side effects.

Description

technical field [0001] The invention relates to an anti-osteomyelitis drug and a preparation process thereof, and belongs to the technical field of medicines and the preparation process thereof. Background technique [0002] Osteomyelitis is an inflammation of bone tissue (including bone marrow, bone, periosteum). The etiology is mostly due to the in vivo or other infection lesions not fully cured or persistent inflammation during the treatment process, which spreads to the bone tissue through the blood circulation. It is called acute hematogenous osteomyelitis in the early clinical stage. If the disease is not treated properly or cured in time in the early stage, it will turn into chronic suppurative osteomyelitis over time, which is relatively stubborn. Clinical surgery often uses surgical marrow replacement or amputation, and the severe pain is unbearable for patients. [0003] At present, Western medicine or traditional Chinese medicine is generally used in the treatmen...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/86A61P19/08
Inventor 曹务波方甫
Owner LAIYANG JIANGBO PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products